Forbes: Healx raises $10m in funding to find medicines for rare diseases

Healx, a Cambridge-based company that seeks breakthroughs for rare diseases through artificial intelligence, announced a $10 million Series A funding round. Healx is supported by the Accelerate Cambridge programme at the Entrepreneurship Centre of Cambridge Judge Business School. The funding will be used to more than double Healx’s team of software engineers, pharmacologists and other professionals, and to expand its artificial intelligence and machine learning technologies.

Read the full article [forbes.com]